VEGF microsphere technology to enhance vascularization in fat grafting

Annals of Plastic Surgery

Volumn 69, Issue 2, 2012, Pages 213-219

  Chung, Christopher W ^a   Marra, Kacey G ^a,b   Li, Han ^a   Leung, Alan S ^a   Ward, Donna H ^a   Tan, Huaping ^a   Kelmendi Doko, Arta ^a   Rubin, J Peter ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

adipose; fat graft; microspheres; VEGF

Indexed keywords

ANGIOGENIC FACTOR; MICROSPHERE; TISSUE SCAFFOLD; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL; ARTICLE; DRUG EFFECT; EVALUATION; FEMALE; GRAFT SURVIVAL; GROWTH, DEVELOPMENT AND AGING; HUMAN; LIPECTOMY; METHODOLOGY; MOUSE; NUDE MOUSE; TISSUE REGENERATION; TRANSPLANTATION; VASCULARIZATION; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE, WHITE; ANGIOGENESIS INDUCING AGENTS; ANIMALS; FEMALE; GRAFT SURVIVAL; GUIDED TISSUE REGENERATION; HUMANS; LIPECTOMY; MICE; MICE, NUDE; MICROSPHERES; NEOVASCULARIZATION, PHYSIOLOGIC; TISSUE SCAFFOLDS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84863988490     PISSN: 01487043     EISSN: None     Source Type: Journal    
DOI: 10.1097/SAP.0b013e3182573827     Document Type: Article

References (32)

1. Zuk PA, Zhu M, Mizuno H, et al. Multilineage cells from human adipose tissue: Implications for cell-based therapies. Tissue Eng. 2001;7:211-228.
2. Marra KG, Brayfield CA, Rubin JP. Adipose stem cell differentiation into smooth muscle cells. Methods Mol Biol. 2011;702:261-268.
3. Miyazaki T, Kitagawa Y, Toriyama K, et al. Isolation of two human fibroblastic cell populations with multiple but distinct potential of mesenchymal differentiation by ceiling culture of mature fat cells from subcutaneous adipose tissue. Differentiation. 2005;73:69-78.
4. Jack GS, Zhang R, Lee M, et al. Urinary bladder smooth muscle engineered from adipose stem cells and a three dimensional synthetic composite. Biomaterials. 2009;30:3259-3270.
5. Nomi M, Atala A, Coppi PD, et al. Principals of neovascularization for tissue engineering. Mol Aspects Med. 2002;23:463-483.
6. Kannan RY, Salacinski HJ, Sales K, et al. The roles of tissue engineering and vascularisation in the development of micro-vascular networks: A review. Biomaterials. 2005;26:1857-1875.
7. Rehman J, Traktuev D, Li J, et al. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation. 2004;109:1292-1298.
8. Kondo K, Shintani S, Shibata R, et al. Implantation of adipose-derived regenerative cells enhances ischemia-induced angiogenesis. Arterioscler Thromb Vasc Biol. 2009;29:61-66.
9. Moon MH, Kim SY, Kim YJ, et al. Human adipose tissueYderived mesenchymal stem cells improve postnatal neovascularization in a mouse model of hindlimb ischemia. Cell Physiol Biochem. 2006;17:279-290.
10. Murohara T, Horowitz JR, Silver M, et al. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation. 1998;97:99-107.
11. Leung DW, Cachianes G, Kuang WJ, et al. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 1989;246:1306-1309.
12. Senger DR, Ledbetter SR, Claffey KP, et al. Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin. Am J Pathol. 1996;149:293-305.
13. Schmidt A, Brixius K, Bloch W. Endothelial precursor cell migration during vasculogenesis. Circ Res. 2007;101:125-136.
14. Shive MS, Anderson JM. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev. 1997;28:5-24.
15. Patil SD, Papadmitrakopoulos F, Burgess DJ. Concurrent delivery of dexamethasone and VEGF for localized inflammation control and angiogenesis. J Control Release. 2007;117:68-79.
16. Borselli C, Ungaro F, Oliviero O, et al. Bioactivation of collagen matrices through sustained VEGF release from PLGA microspheres. J Biomed Mater Res A. 2010;92:94-102.
17. Lee J, Lee KY. Local and sustained vascular endothelial growth factor delivery for angiogenesis using an injectable system. Pharm Res. 2009;26:1739-1744.
18. Cohen S, Yoshioka T, Lucarelli M, et al. Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres. Pharm Res. 1991; 8:713-720.
19. Lu F, Li J, Gao J, et al. Improvement of the survival of human autologous fat transplantation by using VEGF-transfected adipose-derived stem cells. Plast Reconstr Surg. 2009;124:1437-1446.
20. Pu L. Discussion. Improvement of the survival of human autologous fat transplantation by using VEGF-transfected adipose-derived stem cells. Plast Reconstr Surg. 2009;124:1447-1449.
21. Behr B, Tang C, Germann G, et al. Locally applied vascular endothelial growth factor a increases the osteogenic healing capacity of human adiposeYderived stem cells by promoting osteogenic and endothelial differentiation. Stem Cells. 2011;29:286-296.
22. Cao Y, Sun Z, Liao L, et al. Human adipose tissueYderived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivo. Biochem Biophys Res Commun. 2005;332:370-379.
23. Song SY, Chung HM, Sung JH. The pivotal role of VEGF in adipose-derived stem-cellYmediated regeneration. Expert Opin Biol Ther. 2010;10:1529-1537.
24. Haneke E. Skin rejuvenation without a scalpel. I. Fillers. J Cosmet Dermatol. 2006;5:157-167.
25. Karal-Yilmaz O, Serhatli M, Baysal K, et al. Preparation and in vitro characterization of vascular endothelial growth factor (VEGF)Yloaded poly(D,L-lacticco- glycolic acid) microspheres using a double emulsion/solvent evaporation technique. J Microencapsul. 2011;28:46-54.
26. Isner JM. Vascular endothelial growth factor: Gene therapy and therapeutic angiogenesis. Am J Cardiol. 1998; 82:63S-64S.
27. Zuk PA, Zhu M, Ashjian P, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. 2002;13:4279-4295.
28. Murohara T, Shintani S, Kondo K. Autologous adipose-derived regenerative cells for therapeutic angiogenesis. Curr Pharm Des. 2009;15:2784-2790.
29. Folkman J. Angiogenesis and angiogenesis inhibition: An overview. EXS. 1997; 79:1-8.
30. Springer ML, Chen AS, Kraft PE, et al. VEGF gene delivery to muscle: Potential role for vasculogenesis in adults. Mol Cell. 1998;2:549-558.
31. Vincent KA, Jiang C, Boltje I, et al. Gene therapy progress and prospects: Therapeutic angiogenesis for ischemic cardiovascular disease. Gene Ther. 2007; 14:781-789.
32. Sinha VR, Trehan A. Biodegradable microspheres for protein delivery. J Control Release. 2003;90:261-280.